1. OC-0298 MLC tracking for lung cancer SABR is clinically feasible: results of first-in-human clinical trial. (April 2019) Authors: Booth, J.; Caillet, V.; Briggs, A.; Hardcastle, N.; Jayamanne, D.; Szymura, K.; Ricky, O.; Eade, T.; Keall, P. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗